These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1300 related articles for article (PubMed ID: 25369127)

  • 1. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
    Ma DL; Chan DS; Leung CH
    Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of luminescent biotinylation reagents derived from cyclometalated iridium(III) and rhodium(III) bis(pyridylbenzaldehyde) complexes.
    Leung SK; Kwok KY; Zhang KY; Lo KK
    Inorg Chem; 2010 Jun; 49(11):4984-95. PubMed ID: 20465281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonizing STAT3 dimerization with a rhodium(III) complex.
    Ma DL; Liu LJ; Leung KH; Chen YT; Zhong HJ; Chan DS; Wang HM; Leung CH
    Angew Chem Int Ed Engl; 2014 Aug; 53(35):9178-82. PubMed ID: 24889897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
    Lee PK; Law WH; Liu HW; Lo KK
    Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Synthesis of Amphiphilic and Luminescent Tris-Cyclometalated Iridium(III) Complexes Containing Cationic Peptides as Inducers and Detectors of Cell Death via a Calcium-Dependent Pathway.
    Hisamatsu Y; Shibuya A; Suzuki N; Suzuki T; Abe R; Aoki S
    Bioconjug Chem; 2015 May; 26(5):857-79. PubMed ID: 25875312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
    J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luminescent dendritic cyclometalated iridium(III) polypyridine complexes: synthesis, emission behavior, and biological properties.
    Zhang KY; Liu HW; Fong TT; Chen XG; Lo KK
    Inorg Chem; 2010 Jun; 49(12):5432-43. PubMed ID: 20491455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents.
    Almodares Z; Lucas SJ; Crossley BD; Basri AM; Pask CM; Hebden AJ; Phillips RM; McGowan PC
    Inorg Chem; 2014 Jan; 53(2):727-36. PubMed ID: 24397747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-sandwich iridium- and rhodium-based organometallic architectures: rational design, synthesis, characterization, and applications.
    Han YF; Jin GX
    Acc Chem Res; 2014 Dec; 47(12):3571-9. PubMed ID: 25419985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoiridium complexes: anticancer agents and catalysts.
    Liu Z; Sadler PJ
    Acc Chem Res; 2014 Apr; 47(4):1174-85. PubMed ID: 24555658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.
    Ruiz J; Rodríguez V; Cutillas N; Samper KG; Capdevila M; Palacios Ò; Espinosa A
    Dalton Trans; 2012 Nov; 41(41):12847-56. PubMed ID: 22983366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of new polynuclear organometallic Ru(II), Rh(III) and Ir(III) pyridyl ester complexes as in vitro antiparasitic and antitumor agents.
    Chellan P; Land KM; Shokar A; Au A; An SH; Taylor D; Smith PJ; Riedel T; Dyson PJ; Chibale K; Smith GS
    Dalton Trans; 2014 Jan; 43(2):513-26. PubMed ID: 24121555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic bis-cyclometallated iridium(III) phenanthroline complexes with pendant fluorenyl substituents: synthesis, redox, photophysical properties and light-emitting cells.
    Zeng X; Tavasli M; Perepichka IF; Batsanov AS; Bryce MR; Chiang CJ; Rothe C; Monkman AP
    Chemistry; 2008; 14(3):933-43. PubMed ID: 18033698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of various lipophilic substituents on ruthenium(II), rhodium(III) and iridium(III) salicylaldimine-based complexes: synthesis, in vitro cytotoxicity studies and DNA interactions.
    Cassells I; Stringer T; Hutton AT; Prince S; Smith GS
    J Biol Inorg Chem; 2018 Jul; 23(5):763-774. PubMed ID: 29846816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of ferrocene appended Ru(II), Rh(III) and Ir(III) dipyrrinato complexes with DNA/protein, molecular docking and antitumor activity.
    Paitandi RP; Gupta RK; Singh RS; Sharma G; Koch B; Pandey DS
    Eur J Med Chem; 2014 Sep; 84():17-29. PubMed ID: 25014746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization.
    Yellol J; Pérez SA; Yellol G; Zajac J; Donaire A; Vigueras G; Novohradsky V; Janiak C; Brabec V; Ruiz J
    Chem Commun (Camb); 2016 Dec; 52(98):14165-14168. PubMed ID: 27869279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structural characterization of binuclear half-sandwich iridium, rhodium and ruthenium complexes containing 4,4'-dipyridyldisulfide (4DPDS) ligands.
    Han YF; Li H; Fei Y; Lin YJ; Zhang WZ; Jin GX
    Dalton Trans; 2010 Aug; 39(30):7119-24. PubMed ID: 20593103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarities and differences in d
    Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
    J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water reduction systems associated with homoleptic cyclometalated iridium complexes of various 2-phenylpyridines.
    Yuan YJ; Yu ZT; Cai JG; Zheng C; Huang W; Zou ZG
    ChemSusChem; 2013 Aug; 6(8):1357-65. PubMed ID: 23843363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.